People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VitriVax, Inc. | — | Biotechnology | Series B | $29.4M | $136.7M | 2025 |
| Iantech, Inc. | — | Other Health Care | Series A | $12.2M | $246.7M | 2017 |
| InDevR, Inc. | — | Biotechnology | Series A | $10.0M | $71.0M | 2019 |
Glenn Rockman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Glenn Rockman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Lindstrom | 1 | 13 |
| MICHAEL CHANG | 1 | 13 |
| Brian Walsh | 1 | 7 |
| Tsontcho Ianchulev | 1 | 5 |
| Charles Warden | 1 | 5 |
| Louise Brady | 1 | 3 |
| Michael Reynier | 1 | 2 |
| Kathy Rowlen | 1 | 2 |
| Jim Mazzo | 1 | 1 |
| Rene Lorenz | 1 | 1 |
| Theodore Randolph | 1 | 1 |
| Romulo Colindres | 1 | 1 |
| Shannon Rodriguez | 1 | 1 |
| Erica Dawson | 1 | 1 |
| Laura Kuck | 1 | 1 |
| Bruce J. Brumfield, Jr. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.